BMRN
$57.18-2.16%
as of close, Oct 2, 2026
☾ AH $57.18 -2.16%
BioMarin Pharmaceutical Inc.Stock · Health CareNasdaq Composite 0.02%Russell 1000 0.02%US Stock Market 0.02%Russell 3000 0.01%
BMRN financial statements
The full income statement, balance sheet, and cash-flow statement for BioMarin Pharmaceutical Inc. (BMRN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 190.4M2024-09 190.6M2024-12 190.8M2025-03 191.8M2025-06 192.0M2025-09 192.1M2025-12 192.3M2026-03 193.3M2026-06 193.6M+1.7% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 3.22B+12.9% | 2.85B+18.0% | 2.42B+15.4% | 2.10B+13.5% | 1.85B-0.8% | |
| Cost of revenue | 717M+23.6% | 580M+9.1% | 532M+5.8% | 503M+6.9% | 471M-10.3% | |
| Research & development | 922M+23.4% | 747M+0.1% | 747M+15.0% | 650M+3.3% | 629M+0.1% | |
| Selling, general & administrative | 1.15B+14.3% | 1.01B+13.1% | 892M+8.4% | 823M+8.4% | 759M+2.9% | |
| Amortization of intangibles | 19.4M-55.2% | 43.3M-30.5% | 62.2M-7.4% | 67.2M | — | |
| Operating income | 409M-15.4% | 484M+160.6% | 186M+15.4% | 161M+295.5% | -82.3M-89.6% | |
| Interest expense | 10.9M-14.0% | 12.7M-26.9% | 17.3M+8.5% | 16.0M+4.1% | 15.3M-47.7% | |
| Interest & investment income | 74.9M+0.0% | 74.9M+28.4% | 58.3M+223.5% | 18.0M+72.0% | 10.5M-36.9% | |
| Pre-tax income | 482M-10.9% | 542M+187.3% | 189M+26.1% | 150M+298.5% | -75.3M-53.8% | |
| Income tax | 134M+16.3% | 115M+449.3% | 20.9M+161.0% | 8.02M+171.1% | -11.3M+98.8% | |
| 349M-18.3% | 427M+154.6% | 168M+18.4% | 142M+320.9% | -64.1M-107.5% | ||
| Net income to common | 349M-18.3% | 427M+154.6% | 168M+18.4% | 142M+320.9% | -64.1M-107.5% | |
| $1.80-18.6% | $2.21+154.0% | $0.87+16.0% | $0.75+314.3% | -$0.35-107.8% | ||
| EPS (basic) | $1.82-19.1% | $2.25+152.8% | $0.89+17.1% | $0.76+317.1% | -$0.35-107.4% | |
| Weighted-avg shares (basic) | 192M+0.9% | 190M+1.2% | 188M+1.4% | 185M+1.3% | 183M+1.1% | |
| Weighted-avg shares (diluted) | 197M+0.3% | 197M+2.7% | 192M+1.4% | 189M+3.3% | 183M-4.6% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 3.95B+22.3% | 3.23B+9.3% | 2.96B+7.4% | 2.75B+21.0% | 2.27B-2.9% | ||
| Cash & equivalents | 1.31B+39.1% | 943M+24.9% | 755M+4.2% | 725M+23.4% | 587M-9.5% | |
| Accounts receivable | 908M+37.5% | 661M+4.2% | 634M+37.4% | 461M+23.5% | 373M-16.7% | |
| Inventory | 1.30B+5.4% | 1.23B+11.3% | 1.11B+23.8% | 894M+15.1% | 777M+11.2% | |
| Other current assets | 186M-7.8% | 202M+42.5% | 141M+35.3% | 105M-5.4% | 110M-15.0% | |
| 7.59B+8.7% | 6.99B+2.2% | 6.84B+7.3% | 6.38B+6.2% | 6.00B+2.7% | ||
| Property, plant & equipment | 953M-8.7% | 1.04B-2.2% | 1.07B-0.7% | 1.07B+3.7% | 1.04B+0.3% | |
| Operating lease right-of-use | 35.2M+22.9% | 28.7M-32.9% | 42.7M+22.3% | 34.9M-8.5% | 38.2M-17.0% | |
| Goodwill | 196M+0.0% | 196M+0.0% | 196M+0.0% | 196M+0.0% | 196M+0.0% | |
| Intangible assets | 214M-16.2% | 255M-13.4% | 295M-13.0% | 339M-12.9% | 389M-6.9% | |
| Deferred tax assets | 1.51B+1.3% | 1.49B-3.7% | 1.55B+2.7% | 1.51B+3.8% | 1.45B+1.3% | |
| Other non-current assets | 277M+10.2% | 251M+46.6% | 172M-2.7% | 176M+15.9% | 152M+6.9% | |
| 759M+25.0% | 607M-48.4% | 1.18B+99.9% | 589M+7.8% | 546M+11.0% | ||
| Accrued liabilities | 759M+25.0% | 607M-11.1% | 683M+19.2% | 573M+15.0% | 498M+1.2% | |
| Deferred revenue | — | 1.37M-70.4% | 4.62M+549.8% | 711K-89.8% | 6.96M+4476.3% | |
| Short-term & current debt | 0.00 | — | — | — | — | |
| Current lease liability | 8.57M+18.5% | 7.23M-16.3% | 8.64M+6.8% | 8.09M-1.3% | 8.20M-7.8% | |
| Finance lease liability (current) | 116K-66.0% | 341K+145.3% | 139K-93.9% | 2.29M+0.9% | 2.27M-20.9% | |
| 1.51B+13.2% | 1.33B-29.6% | 1.89B+6.7% | 1.77B+1.9% | 1.74B-0.2% | ||
| Long-term debt | 597M | — | — | — | — | |
| Non-current lease liability | 36.6M+19.9% | 30.5M-19.8% | 38.0M+44.5% | 26.3M-17.4% | 31.9M-21.2% | |
| Operating lease liability (total) | 45.1M+19.6% | 37.7M-19.2% | 46.7M+35.7% | 34.4M-14.1% | 40.1M-18.8% | |
| Finance lease liability (total) | 552K-49.7% | 1.10M+407.9% | 216K-91.3% | 2.47M-41.5% | 4.23M-38.5% | |
| Finance lease liability | 436K-42.3% | 756K+881.8% | 77.0K-58.2% | 184K-90.6% | 1.96M-51.1% | |
| Other non-current liabilities | 151M+17.1% | 129M+7.4% | 120M+19.9% | 100M+1.7% | 98.4M-13.9% | |
| 6.09B+7.6% | 5.66B+14.3% | 4.95B+7.6% | 4.60B+7.9% | 4.27B+4.0% | ||
| Common stock | 192K+0.5% | 191K+1.1% | 189K+1.6% | 186K+1.1% | 184K+1.1% | |
| Additional paid-in capital | 5.96B+2.7% | 5.80B+3.4% | 5.61B+3.8% | 5.40B+4.1% | 5.19B+4.0% | |
| Retained earnings | 154M+179.2% | -195M+68.7% | -622M+21.2% | -789M+15.2% | -931M-8.0% | |
| Accumulated other comprehensive income | -13.5M-121.9% | 61.7M+314.2% | -28.8M-644.5% | -3.87M-126.8% | 14.4M+189.4% | |
| Total liabilities & equity | 7.59B+8.7% | 6.99B+2.2% | 6.84B+7.3% | 6.38B+6.2% | 6.00B+2.7% | |
| Common shares issued | 192M+0.8% | 191M+1.1% | 189M+1.3% | 186M+1.3% | 184M+1.2% | |
| Common shares outstanding | 192M+0.8% | 191M+1.1% | 189M+1.3% | 186M+1.3% | 184M+1.2% | |
| Shares outstanding (cover) | 192M+0.8% | 191M+1.1% | 189M+1.2% | 187M+1.4% | 184M+1.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 828M+44.5% | 573M+259.7% | 159M-9.5% | 176M-42.2% | 305M+256.7% | ||
| Depreciation & amortization | 79.6M-17.5% | 96.4M-7.6% | 104M+2.4% | 102M-5.6% | 108M+2.7% | |
| Intangible amortization | 19.4M-55.2% | 43.3M-30.5% | 62.2M-7.4% | 67.2M | — | |
| Share-based compensation | 181M-10.0% | 202M-2.7% | 207M+5.5% | 196M-0.5% | 197M+4.0% | |
| Deferred income taxes | 48.7M-13.1% | 56.1M+224.7% | -45.0M+13.6% | -52.1M-233.7% | -15.6M+98.2% | |
| Change in receivables | 228M+293.8% | 57.9M-69.6% | 190M+132.1% | 82.0M+225.1% | -65.6M-211.1% | |
| Change in inventory | 117M+84.1% | 63.5M-59.5% | 157M+130.1% | 68.3M+94.7% | 35.1M-42.7% | |
| -414M-403.5% | 136M+222.7% | -111M-455.4% | -20.0M+94.5% | -366M-583.2% | ||
| Capital expenditure | 103M+20.6% | 85.4M-11.7% | 96.7M-20.1% | 121M+26.6% | 95.6M-16.4% | |
| Free cash flow | 725M+48.7% | 487M+679.0% | 62.6M+13.9% | 54.9M-73.7% | 209M+821.9% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchases of investments | 356M-13.3% | 410M-52.8% | 868M+42.0% | 612M-34.7% | 937M+76.9% | |
| Sales/maturities of investments | 338M-46.6% | 633M-26.8% | 865M+39.5% | 620M-10.3% | 691M+24.3% | |
| Other investing activities | 0.00+100.0% | -1.14M | 0.00 | 0.00-100.0% | 994K+37.5% | |
| -42.4M+91.9% | -526M-2711.2% | -18.7M-0.4% | -18.6M-38754.2% | -48.0K-100.0% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | -889K+72.0% | -3.18M+73.0% | -11.8M-351.5% | -2.60M-554.5% | -398K | |
| FX effect on cash | — | — | — | — | -57.0K+95.0% | |
| Net change in cash | 369M+96.5% | 188M+513.5% | 30.6M-77.7% | 137M+321.8% | -61.9M-129.2% | |
| Interest paid | 7.25M-30.1% | 10.4M+0.6% | 10.3M+0.2% | 10.3M-1.1% | 10.4M-14.6% | |
| Income taxes paid | 96.2M+68.0% | 57.3M-21.9% | 73.3M+34.8% | 54.4M+199.5% | 18.2M+102.2% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 11.4B-8.9% | 12.5B-31.0% | 18.2B-5.6% | 19.2B+18.3% | 16.3B+2.0% | |
| P/E | 32.8×+11.5% | 29.4×-76.2% | 123.5×-46.1% | 229.2× | — | |
| P/S | 3.5×-19.2% | 4.4×-44.1% | 7.9×-17.9% | 9.6×+8.7% | 8.8×+2.8% | |
| P/B | 1.9×-15.3% | 2.2×-40.2% | 3.7×-11.9% | 4.2×+10.5% | 3.8×-2.0% | |
| P/FCF | 15.8×-38.7% | 25.7×-95.0% | 517.4×+78.3% | 290.2×+272.9% | 77.8× | |
| Earnings yield | 3.1%-10.3% | 3.4%+320.5% | 0.81%+85.5% | 0.44% | — | |
| FCF yield | 6.3%+63.2% | 3.9%+1911.3% | 0.19%-43.9% | 0.34%-73.2% | 1.3% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: BMRN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BMRN filings on SEC EDGAR → Not investment advice.